Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

BUPIVACAINE AND EPI

Closed
SPE2DP-26-T-3438Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 21 days

AI Contract Overview

Show more

The contract involves the procurement of Bupivacaine Hydrochloride with Epinephrine injection, USP, specifically a 0.5% solution with epinephrine at a 1:200,000 ratio, packaged in single-dose vials with a strength of 5 mg/mL. The drug is preservative-free, prescription-only, and supplied in packages containing 10 vials each. It has a total shelf life of 18 months, and the government requires a minimum of 15 months remaining shelf life upon receipt. Storage conditions specify controlled room temperature between 20 to 25°C (68 to 77°F). Labeling must include the national stock number, manufacturer information, lot number, contract number, and manufacturing and expiration or retest dates. Packaging must adhere to Defense Logistics Agency (DLA) standards to ensure protection from damage, marked according to Medical Marking Standard No. 1, and comply with applicable commercial and military packaging requirements. The contract details specify delivery to Fort Bragg, North Carolina, with a delivery timeframe of 20 days and acceptance at the destination point. Shipping must be executed by traceable means (parcel post is prohibited), and packaging shall comply with DLA technical and quality requirements and applicable standards for hazardous or non-hazardous materials. The purchase involves a quantity of three packages, each containing 10 single-dose vials. The solicitation was issued by the Department of Defense through the Medical Supply Chain Pharm FSA under solicitation number SPE2DP-26-T-3438, with responses due by May 26, 2026. The primary point of contact for this procurement is Morgan Kelly.

General Info

Procurement of preservative-free Bupivacaine with Epinephrine, 30 vials, 20-day delivery to Fort Bragg.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3438 Medical Supply Chain

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Office AddressUS

Full Description

Show more
BUPIVACAINE AND EPI
BUPIVACAINE AND EPINEPHRINE INJECTION,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
0.5% WITH EPINEPHRINE 1:200,000
CONTAINS 5 MG BUPIVACAINE HYDROCHLORIDE PER ML.
.
GENERIC NAME: BUPIVACAINE HCL/EPINEPHRINE/PF
ROUTE: INJECTION
DOSE FORM: VIAL (ML)
STRENGTH: 5 MG/ML (0.5 %)-1:200,000
1 PG = 10 EA
UNIT OF ISSUE IS A PACKAGE OF 10 SINGLE-DOSE
VIALS (EACH)
.
PRESCRIPTION ONLY, PRESERVATIVE FREE
.
TOTAL SHELF LIFE IS 18 MONTHS
.
THERE SHALL BE A MINIMUM OF 15 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF
RECEIPT BY THE FIRST GOVERNMENT ACTIVITY
.
STORE AT 20 TO 25°C (68 TO 77°F).
[SEE USP CONTROLLED ROOM TEMPERATURE.]
.
LABELING AND MARKING:
MUST INCLUDE:
NATIONAL STOCK NUMBER
MANUFACTURER
DATE OF MANUFACTURER, EXPIRATION DATE OR RETEST DATE
CONTRACT NUMBER
LOT NUMBER
.
11/16/2014
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
SPE2DP-26-T-3438
SECTION B
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
PFIZER INC 86491 P/N NDC00409-1749-29
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016803158 0001 PG 3.000
NSN/MATERIAL:6505011277947
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
SPE2DP-26-T-3438
SECTION B
PR: 7016803158 PRLI: 0001 CONT’D
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
MARKFOR
W91KBP
0003 SF BN 01 CO A SUSTAINMEN
3D SFG SSA AWCF SSF
5234 EAGLE TALON DR BLDG X3063
FORT BRAGG NC 28310
US
M/F: (TCN) W91KBP61340287
RDD: 148
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:05/19/2026
SPE2DP-26-T-3438 NSN/Part Number: 6505-01-127-7947 Quantity: 3 PG Purchase Request: 7016803158QTY: 3 Delivery: 20 days ADO